Network Meta-analysis of single Hirudo prescriptions in treatment of ischemic cerebrovascular disease.
10.19540/j.cnki.cjcmm.20221014.503
- Author:
Zao-Fang YAN
1
;
Rui-Hua SUN
2
;
Yan-Fen CHEN
2
;
Kang-da YU
3
Author Information
1. Beijing University of Chinese Medicine Beijing 100029, China.
2. China-Japan Friendship Hospital Beijing 100029, China.
3. Beijing Inruida Pharmaceutical Technology Co., Ltd. Beijing 102218, China.
- Publication Type:Journal Article
- Keywords:
efficacy;
ischemic cerebrovascular disease;
network Meta-analysis;
safety;
single Hirudo prescriptions;
traditional Meta-analysis
- MeSH:
Humans;
Animals;
Capsules;
Network Meta-Analysis;
Combined Modality Therapy;
Leeches;
Prescriptions;
Cerebrovascular Disorders
- From:
China Journal of Chinese Materia Medica
2023;48(4):1108-1115
- CountryChina
- Language:Chinese
-
Abstract:
This study intended to evaluate the efficacy and safety of single Hirudo prescriptions in the treatment of ischemic cerebrovascular disease(ICVD) by frequency network Meta-analysis and traditional Meta-analysis. CNKI, Wanfang, VIP, SinoMed, PubMed, EMbase, and Cochrane Library databases were searched to collect the randomized controlled trial(RCT) of single Hirudo prescriptions for ICVD from the inception of the databases to May 2022. The quality of the included literature was evaluated by Cochrane risk of bias tool. Finally, 54 RCTs and 3 single Hirudo prescriptions were included. Statistical analysis was conducted by RevMan 5.3 and Stata SE 15. Network Meta-analysis showed that in terms of the clinical effective rate, the surface under the cumulative ranking curve(SUCRA) of intervention measures was as follows: Huoxue Tongmai Capsules+conventional treatment>Maixuekang Capsules+conventional treatment>Naoxuekang Capsules+conventional treatment>conventional treatment. Traditional Meta-analysis revealed that in terms of the safety of ICVD treatment, Maixuekang Capsules+conventional treatment had higher safety than conventional treatment alone. According to the network Meta-analysis and traditional Meta-analysis, it was found that conventional treatment combined with single Hirudo prescriptions improved the clinical efficacy of ICVD patients, and compared with that of conventional treatment alone, the incidence of adverse reactions of combined treatment was low and the safety was high. However, the methodological quality of the articles included in this study was generally low and there were large differences in the number of articles on the three combined medication. Therefore, the conclusion of this study needed to be confirmed by subsequent RCT.
